HALL PRIVATE WEALTH ADVISORS – Regeneron Pharmaceuticals, Inc. Transaction History
HALL PRIVATE WEALTH ADVISORS portfolio value:
$5.60M
portfolio value
HALL PRIVATE WEALTH ADVISORS quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.43% | 115 shares | 863K | $688.87 | 8.14K |
| Q2 2022 | share | Decrease | -24.73% | -2.63K shares | -2.70M | $591.13 | 8.02K |
| Q1 2022 | share | Increase | +2.38% | 248 shares | 870K | $698.42 | 10.66K |
| Q4 2021 | share | Increase | +0.62% | 64 shares | 313K | $642.51 | 10.41K |
| Q3 2021 | share | Increase | +6.71% | 651 shares | 847K | $605.18 | 10.35K |
| Q2 2021 | share | Increase | +399.95% | 7.75K shares | 4.48M | $558.54 | 9.69K |
| Q4 2020 | share | Increase | 0.00% | 1.94K shares | 937K | $483.11 | 1.94K |